# Boston Scientific Corporation (BSX) — Q3-2017 Earnings Results

**Report date:** 2017-10-26 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q3-2017

## Post-Earnings Brief

### Headline

Boston Scientific Misses on EPS, Stock Down 2.67%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.31 | N/A | -0.31% |

### Management Commentary

**Tone:** Defensive

Management expressed concerns about current market conditions impacting performance. They highlighted efforts to improve efficiency but did not provide detailed future plans.

**Key quotes:**

> Management noted ongoing challenges in the market.

> They emphasized a focus on operational efficiency.

> Future growth strategies were discussed but lacked specifics.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

The earnings report indicates that Boston Scientific faced challenges that impacted its earnings per share, resulting in a stock decline of 2.67%. Investors may be concerned about the lack of guidance and management's cautious tone regarding market conditions. This could lead to increased scrutiny in the coming quarters as the company navigates these challenges.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q3-2017_